Calendrier des promotions Guardant Health, Inc.
À propos de l'entreprise
Guardant Health, Inc., компания, специализирующаяся на точной онкологии, предоставляет анализы крови, наборы данных и аналитику в США и за рубежом. Компания предлагает тесты жидкой биопсии для рака поздней стадии, такие как Guardant360, молекулярный диагностический тест, который измеряет различные гены, связанные с раком; и GuardantOMNI, более широкая панель генов, включающая гены, связанные с дефицитом восстановления гомологичной рекомбинации, и биомаркеры для иммуноонкологических приложений.
Plus de détailsP/S | 33.12 |
---|---|
P/BV | 8.37 |
EV/EBITDA | -101.98 |
EBITDA | -0.0685 |
Цена ао | 23.07 |
Сайт | http://guardanthealth.com |
Число акций ао | 0.11199 млрд |
Выручка | 0.2144 |
Див.доход ао | 0 |
ISIN | US40131M1099 |
Валюта | usd |
IPO date | 2018-10-04 |
Sector | Health Care |
Industry | Health Care Providers & Services |
Валюта отчета | usd |
Changement de prix par jour: | +1.5% (22.73) |
---|---|
Changement de prix par semaine: | +9.6% (21.05) |
Changement de prix par mois: | -13.89% (26.79) |
Changement de prix sur 3 mois: | -31.81% (33.83) |
Changement de prix sur six mois: | +38.39% (16.67) |
Changement de prix par an: | -15.53% (27.31) |
Evolution du prix sur 3 ans: | -76.36% (97.58) |
Evolution du prix sur 5 ans: | -70.44% (78.04) |
Evolution des prix depuis le début de l'année: | -14.17% (26.88) |
|
Sous-estimation
|
Efficacité
|
|||||||||||||||||||||||||||||||||||||
Dividendes
|
Devoir
|
Impulsion de croissance
|
Date de transaction | Date de divulgation | Insider | Taper | Prix | Volume | Quantité | Partagez jusqu'à, % | Partager après, % | Document |
---|---|---|---|---|---|---|---|---|---|
04.10.2024 | 07.10.2024 | Joyce Meghan V. Director |
Achat | 21.35 | 1 409 | 66 | 0 | 0 | lien |
04.07.2024 | 08.07.2024 | Joyce Meghan V. Director |
Achat | 27.57 | 1 820 | 66 | 0 | 0 | lien |
31.03.2024 | 01.04.2024 | Eltoukhy Helmy Co-Chief Executive Officer |
Achat | 20.25 | 232 085 | 11461 | 0 | 0.01 | lien |
31.03.2024 | 01.04.2024 | Talasaz AmirAli Co-Chief Executive Officer |
Achat | 20.25 | 232 085 | 11461 | 0 | 0.01 | lien |
04.03.2024 | 05.03.2024 | Joyce Meghan V. Director |
Vente | 19.05 | 1 905 | 100 | 0 | 0 | lien |
04.03.2024 | 05.03.2024 | Joyce Meghan V. Director |
Achat | 18.73 | 1 236 | 66 | 0 | 0 | lien |
01.12.2023 | 04.12.2023 | Chudova Darya Chief Technology Officer |
Achat | 26.95 | 8 489 | 315 | 0 | 0 | lien |
01.12.2023 | 04.12.2023 | Kalia Kumud Chief Information Officer |
Vente | 26.37 | 152 946 | 5800 | 0 | -0.01 | lien |
01.12.2023 | 04.12.2023 | Kalia Kumud Chief Information Officer |
Achat | 26.95 | 19 135 | 710 | 0 | 0 | lien |
01.12.2023 | 04.12.2023 | Merrill Amelia SVP, People |
Achat | 26.95 | 4 258 | 158 | 0 | 0 | lien |
01.12.2023 | 04.12.2023 | Saia John G. Chief Legal Officer |
Achat | 26.95 | 7 088 | 263 | 0 | 0 | lien |
30.11.2023 | 04.12.2023 | Krognes Steve E. Director |
Achat | 26.95 | 4 150 | 154 | 0 | 0 | lien |
15.09.2023 | 19.09.2023 | Bell Michael Brian Chief Financial Officer |
Achat | 32.38 | 39 925 | 1233 | 0 | 0 | lien |
15.09.2023 | 19.09.2023 | POTTER MYRTLE S Director |
Achat | 32.38 | 2 234 | 69 | 0 | 0 | lien |
12.09.2023 | 13.09.2023 | Kalia Kumud Chief Information Officer |
Vente | 32.59 | 69 254 | 2125 | 0 | 0 | lien |
15.01.2023 | 17.01.2023 | POTTER MYRTLE S Director |
Achat | 31.12 | 2 116 | 68 | 0 | 0 | lien |
15.01.2023 | 17.01.2023 | Bell Michael Brian CHIEF FINANCIAL OFFICER |
Achat | 31.12 | 102 976 | 3309 | 0 | 0 | lien |
04.01.2023 | 05.01.2023 | Joyce Meghan V. Director |
Achat | 27.32 | 1 830 | 67 | 0 | 0 | lien |
13.08.2021 | 17.08.2021 | Eltoukhy Helmy Co-Chief Executive Officer |
Achat | 4.18 | 99 998 | 23923 | 0 | 0.02 | lien |
13.08.2021 | 17.08.2021 | Talasaz AmirAli Co-Chief Executive Officer |
Achat | 4.18 | 99 998 | 23923 | 0 | 0.02 | lien |
19.04.2021 | 19.04.2021 | Eltoukhy Helmy Chief Executive Officer |
Vente | 152.97 | 7 791 070 | 50932 | 0 | -0.05 | lien |
16.04.2021 | 19.04.2021 | Eltoukhy Helmy Chief Executive Officer |
Vente | 158.34 | 8 094 820 | 51123 | 0 | -0.05 | lien |
15.04.2021 | 19.04.2021 | Eltoukhy Helmy Chief Executive Officer |
Vente | 158.85 | 24 956 400 | 157107 | 0 | -0.17 | lien |
11.02.2021 | 12.02.2021 | Talasaz AmirAli Chairman, President and COO |
Vente | 166.56 | 3 918 990 | 23529 | 0 | -0.03 | lien |
11.02.2021 | 12.02.2021 | Talasaz AmirAli Chairman, President and COO |
Vente | 166.98 | 33 771 900 | 202251 | 0 | -0.22 | lien |
10.02.2021 | 12.02.2021 | Talasaz AmirAli Chairman, President and COO |
Vente | 160.9 | 1 398 060 | 8689 | 0 | -0.01 | lien |
10.02.2021 | 12.02.2021 | Talasaz AmirAli Chairman, President and COO |
Vente | 160.9 | 9 381 110 | 58304 | 0 | -0.06 | lien |
Établissements | Volume | Partager, % |
---|---|---|
Vanguard Group Inc | 11130654 | 9.15 |
Blackrock Inc. | 10831716 | 8.9 |
Baillie Gifford and Company | 6178812 | 5.08 |
FMR, LLC | 5251349 | 4.31 |
Deep Track Capital, LP | 5000000 | 4.11 |
Capital International Investors | 4001803 | 3.29 |
Eventide Asset Management LLC | 3888146 | 3.19 |
AllianceBernstein L.P. | 3708283 | 3.05 |
Temasek Holdings (Private) Limited | 3673243 | 3.02 |
Parkwood LLC | 2800000 | 2.3 |
Superviseur | Titre d'emploi | Paiement | Année de naissance |
---|---|---|---|
Dr. Helmy Eltoukhy Ph.D. | Co-Founder, Co-CEO & Chairman | 11.63k | 1979 (45 années) |
Mr. John G. Saia | Chief Legal Officer & Corporate Secretary | 627.18k | 1973 (51 année) |
Mr. Michael Bell | Chief Financial Officer | 630.99k | 1969 (55 années) |
Mr. Kumud Kalia | Chief Information Officer | N/A | 1966 (58 années) |
Dr. AmirAli Talasaz Ph.D. | Co-CEO & Director | 11.18k | 1980 (44 année) |
Ms. Jennifer Higgins | Senior Vice President of Public Affairs | N/A | |
Dr. Craig Eagle M.D. | Chief Medical Officer | 649.13k | 1967 (57 années) |
Mr. Christopher Freeman | Chief Commercial Officer | 630.39k | 1974 (50 années) |
Ms. Darya Chudova | Chief Technology Officer | N/A | 1974 (50 années) |
Zarak Khurshid | Vice President of Investor Relations |
Site web: http://guardanthealth.com